Literature DB >> 15490400

C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries.

Eiji Ishimura1, Senji Okuno, Kayoko Kitatani, Kiyoshi Maekawa, Tsuyoshi Izumotani, Tomoyuki Yamakawa, Shuichi Jono, Tetsuo Shoji, Atsushi Shioi, Masaaki Inaba, Shaul G Massry, Yoshiki Nishizawa.   

Abstract

Although evidence has accumulated indicating a close relationship between inflammation and atherosclerosis, the relationship between inflammation and vascular calcification in patients with chronic renal failure is unclear. In the present study, the relationship between C-reactive protein (CRP) and vascular calcification in dialysis patients was examined. Vascular calcification of the aorta and hand arteries of 512 hemodialysis patients without significant infection (age 58.8 +/- 10.1 y; 305 men, 207 women) were examined by roentgenography of the lateral abdomen and hands, respectively. Patients with a mean CRP level greater than 1.0 mg/L (n = 254) were older than those with a CRP level less than or equal to 1.0 mg/L (n = 258) and had a longer duration of dialysis, lower serum albumin level, and higher phosphate level ( P < .01, P < .05, P < .001, and P < .01, respectively). Prevalence of vascular calcification of aorta and hand arteries in the former group was significantly higher than in the latter (65.0% versus 43.8% for aorta, P < .0001; and 25.0% versus 14.7% for hand arteries, P < .01). In a multivariate logistic regression analysis adjusted for age, hemodialysis duration, sex, levels of calcium and phosphate, and presence of diabetes, CRP level was a significant predictor for the presence of aortic calcification (odds ratio for highest versus lowest quartile, 2.669; 95% confidence interval, 1.539-5.421, P = .0010) and of calcification of hand arteries (odds ratio, 2.243; 95% confidence interval, 1.039-4.841; P = .0395). In conclusion, the present study shows that increased levels of CRP are significantly associated with the presence of vascular calcification in both aorta and hand arteries (ie, with both atheromatous and medial forms of calcification), indicating evidence for a relationship between inflammation and vascular calcification in hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490400     DOI: 10.1016/j.semnephrol.2004.06.008

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  9 in total

1.  Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients.

Authors:  M Inaba; S Okuno; Y Imanishi; S Yamada; A Shioi; T Yamakawa; E Ishimura; Y Nishizawa
Journal:  Osteoporos Int       Date:  2006-08-05       Impact factor: 4.507

2.  Prevalence of abdominal artery calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis.

Authors:  Zhihui Yao; Congxia Wang; Qiaona Zhang; Shan Ma; Baosong Gui; Chaoyang Duan
Journal:  Int Urol Nephrol       Date:  2017-09-21       Impact factor: 2.370

3.  Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients.

Authors:  Kamal M Okasha; Mohamed Hussein Aboufreikha; Waleed Elrefaey; Medhat M Ashmawy; Heba Mourad; Mohamed A Elsebaey; Mohammed H Elnaggar; Raghda Gabr Mashaal; Sama Metwally; Shaimaa Samir Amin Mashal; Neveen A Shalaby; Shireen Ali Elhoseny; Amr Alkassas; Mohammed Elbarbary; Osama Shoeib; Dina A Ali; Nivin Baiomy; Sherein M Alnabawy
Journal:  Front Med (Lausanne)       Date:  2022-06-22

4.  Clinical assessment of atherosclerotic parameters and cardiac function in chronic hemodialysis patients.

Authors:  Mayuko Akamatsu; Tetsuya Ogawa; Ayuko Fujiu; Nami Matsuda; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2009-08-14       Impact factor: 2.801

Review 5.  Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.

Authors:  Melvin R Hayden; Suresh C Tyagi; Lisa Kolb; James R Sowers; Ramesh Khanna
Journal:  Cardiovasc Diabetol       Date:  2005-03-18       Impact factor: 9.951

6.  Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients.

Authors:  Tarek Z El Baz; Osama A Khamis; Amal El-Shehaby; Hussein Chahine; Ahmad Alaa Al-Din Ahmed; Mostafa A Alsawasany
Journal:  Egypt Heart J       Date:  2017-03-09

7.  Malnutrition, inflammation, progression of vascular calcification and survival: Inter-relationships in hemodialysis patients.

Authors:  Sun Ryoung Choi; Young-Ki Lee; A Jin Cho; Hayne Cho Park; Chae Hoon Han; Myung-Jin Choi; Ja-Ryong Koo; Jong-Woo Yoon; Jung Woo Noh
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

8.  The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts.

Authors:  Carla Viegas; Nuna Araújo; Catarina Marreiros; Dina Simes
Journal:  Aging (Albany NY)       Date:  2019-06-26       Impact factor: 5.682

Review 9.  Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation.

Authors:  Kerstin Benz; Karl-Friedrich Hilgers; Christoph Daniel; Kerstin Amann
Journal:  Int J Nephrol       Date:  2018-08-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.